Blend Labs Exec Nima Ghamsari Sells 21,009 Shares in Quiet 10b5‑1 Plan as Stock Slumps 24% This Month

Insider Activity Spotlight: Blend Labs’ Recent Share Sale Signals a Quiet Shift

On September 21, 2026, Head of Blend Nima Ghamsari sold 21,009 shares of Class A common stock under a Rule 10b5‑1 trading plan. At a weighted average price of $1.19, the transaction reduces his post‑trade holding to 7,850,361 shares—just under 3 % of the outstanding equity. While the sale was executed through a pre‑approved plan and not a “material change of control” event, the timing and volume invite interpretation.

What the Numbers Mean for Investors

Blend’s share price has slumped 24 % this month and 70 % year‑to‑date, underscoring volatility in the mortgage‑tech niche. Ghamsari’s sale is modest relative to the market cap (~$265 million), yet it follows a broader pattern of insider buying and selling that suggests a “balanced” approach to portfolio management rather than panic. For the average shareholder, the sale does not signal an imminent decline, but it does indicate that senior executives are actively managing risk exposure during a bear cycle. If the company continues to deliver incremental product releases and secure new lending partnerships, insiders may keep buying to support the stock’s recovery.

Ghamsari Nima: A Profile of Steady Balancing

Ghamsari’s trading history over the past six months reflects a disciplined, rule‑based strategy. He has alternated between sizable buys (e.g., 375,000 shares on May 20) and disciplined sells (e.g., 241,701 shares on August 20). He also sells restricted‑stock‑unit (RSU) blocks—125,000, 375,000, and 114,229 shares—each time the RSUs vest or the company’s valuation peaks. These moves align with typical RSU‑lapse timing: a 90‑day window after the vesting date, often when the company’s share price is above a certain threshold. The pattern suggests that Ghamsari’s primary motivation is to lock in gains rather than to signal negative sentiment.

Implications for Blend’s Future

With a negative price‑earnings ratio of –18.12, Blend remains fundamentally fragile. Yet the company’s 52‑week low of $1.08 and current price of $1.12 provide a narrow margin for error. Insider activity, especially from the Head of Blend, can be read as a “confidence gauge.” The recent sale is modest, but if accompanied by further insider buys—perhaps as the company closes a new loan‑origination platform or expands into European markets—it could reassure the market. Conversely, a cluster of outsized sales would raise red flags.

Key Takeaways for Financial Professionals

• Rule‑based sales: The 10b5‑1 plan mitigates insider‑trade concerns but still signals strategic liquidity management.
• RSU‑lapse patterns: Regular RSU sales align with vesting windows, indicating a routine “tax‑efficient” exercise strategy.
• Market context: Blend’s steep decline and negative P/E emphasize the need for cautious optimism; insider activity can provide a barometer of management’s faith in the company’s trajectory.

For investors watching BLEND LABS, Ghamsari’s recent sell is a small drop in a larger, ongoing narrative of cautious balance—one that may either buoy confidence in a turnaround or caution against a deeper slide.